tirzepatide phase 3 Efficacy of in 2 (GPGB; [14]) and phase (SURPASS-1 Overview of the SURPASS phase

Enhanced Metabolic Health: Weight loss achieved with semaglutide powder can lead to improvements in metabolic markers such as reduced blood pressure, improved cholesterol levels, and enhanced insulin sensitivity

A separate research letter published in JAMA identified an average percentage of days covered (PDC) of 54% in patients with obesity and without diabetes 12 months after GLP-1 RA initiation

A follow-up study demonstrated that AOD-9604 stimulated lipolysis and simultaneously inhibited lipogenesis in isolated adipocytes

This is particularly relevant for gut health applications, where the peptide needs to interact with the intestinal lining over an extended period

Left-hand panel shows abundance of AKR1B10 from healthy individuals and those with MASH in the independent cohort

This mechanism helps reduce appetite but also prolongs the time collagen and other proteins spend in the stomach